ReviMo's Robotic Transfer Device Aims to Replace the Hoyer Lift

For a person with significant mobility challenges, a simple transfer from bed to chair is often a two-person job. It is a moment of profound dependence, a logistical hurdle that can dictate the rhythm of a day and strain the physical health of caregivers. ReviMo, a Boston-based robotics startup, is betting that a compact, remote-controlled robot can turn that chore into a one-person operation, aiming to replace the bulky, manually operated Hoyer lifts that have defined the category for decades [ReviMo, retrieved 2024].

A robotic wedge into patient transfers

The company's first product, called Niko, is a robotic mobility assistant designed to navigate to a bedside, perform a seated lift, and transport an individual for self-care tasks like toileting. Its core promise is autonomy for the user and relief for the caregiver, a value proposition that targets both the home and the healthcare facility [PERPLEXITY SONAR PRO BRIEF, Unknown]. The technical wedge rests on a patent-pending seating mechanism and remote control, allowing the user to summon and direct the device without physical assistance. This positions Niko as an alternative to ceiling-track systems and traditional mobile lifts, which often require significant strength to operate and dedicated installation space [Disabled Life Alliance, 2023 or later].

Early validation and a solo founder's path

Founded in 2022 by Aleksandr Malashchenko, a PhD in Mechanical Engineering and Babson College MBA, ReviMo has navigated the early-stage gauntlet as a solo founder [Jennifer DiMartino - Passionate & dedicated..., retrieved 2026]. The company has secured validation through selective accelerators, including the Techstars Physical Health Fort Worth 2024 cohort and the AgeTech Collaborative from AARP [AgeTech Collaborative from AARP]. It is also a resident startup at MassRobotics, a Boston hub for hardware innovation [David Barsoum - Prev @ ReviMo | Robotics @ Olin..., retrieved 2026]. While the precise amount of its pre-seed funding is undisclosed, third-party estimates model the company's annual revenue at approximately $342,220, with an estimated valuation near $1.1 million [Prospeo, Unknown].

The competitive and regulatory landscape

ReviMo does not enter an empty field. It faces established competitors like IndeeLift and Altimate Medical, which manufacture mechanical patient lifts. The startup's bet is that robotic assistance and user-controlled operation represent a meaningful step-change in dignity and practicality. However, the path to market is gated by regulatory certification, a non-negotiable hurdle for any medical-adjacent hardware. The company states it is in the final stages of launching production and completing this certification, a phase that will determine its commercial timeline [ReviMo, retrieved 2024]. The business model must also navigate two distinct sales motions: the slower, often grant-funded individual purchase for home use, and the bulk procurement cycles of institutional buyers.

Key challenges for ReviMo's next phase include:

• Regulatory clearance. Final certification is the immediate gate before any commercial rollout can begin.
• Production scale. Moving from prototypes to reliable, cost-effective manufacturing is a classic hardware hurdle.
• Market education. Convincing care facilities and individuals to adopt a new technology over familiar tools requires clear evidence of reduced caregiver injury and improved patient outcomes.

The standard of care today

The condition ReviMo addresses is impaired mobility, a broad patient population encompassing individuals with spinal cord injuries, advanced neuromuscular diseases, severe arthritis, and the frail elderly. For many of these people, the current standard of care for transfers involves a family member or nurse physically lifting them, or the use of a manual Hoyer lift,a sling-based device that requires a caregiver to pump a hydraulic lever. These methods preserve life, but they can compromise patient dignity and are a leading cause of musculoskeletal injuries among healthcare workers. ReviMo's Niko is an attempt to rewrite that script, placing control back with the patient and aiming to turn a moment of vulnerability into one of regained agency. The next twelve months will show if the robot can clear its final certifications and begin to prove that case in real homes and care settings.

Sources

1. [ReviMo, retrieved 2024] ReviMo - Mobility | Smart Robotic Mobility Device | Boston, USA | https://www.revimo.care/
2. [PERPLEXITY SONAR PRO BRIEF, Unknown] Web-grounded research brief on ReviMo's product and market.
3. [Disabled Life Alliance, 2023 or later] ReviMo | disAbled Life Alliance | https://disabledlifealliance.com/disabled-life-innovation-gateway/listings/revimo/
4. [Jennifer DiMartino - Passionate & dedicated..., retrieved 2026] LinkedIn profile noting Aleksandr Malashchenko's PhD | https://www.linkedin.com/in/jendimartino/
5. [AgeTech Collaborative from AARP] Company Profile - ReviMo | https://home.agetechcollaborative.org/startup/network/findacompany/companyprofile?UserKey=
6. [Techstars Physical Health Fort Worth Announces 11 Companies in Its 2024 Accelerator » Dallas Innovates] | https://dallasinnovates.com/techstars-physical-health-fort-worth-announces-11-companies-in-its-2024-accelerator/
7. [David Barsoum - Prev @ ReviMo | Robotics @ Olin..., retrieved 2026] LinkedIn profile noting MassRobotics residency | https://www.linkedin.com/in/davidmbarsoum/
8. [Prospeo, Unknown] Prospeo company profile with revenue and valuation estimates.
9. [MassRobotics Reveals the 2025 Healthcare Robotics Catalyst Program - News, retrieved 2026] | https://control.com/news/massrobotics-reveals-the-2025-healthcare-robotics-catalyst-program/